Jet Lag Study Includes Private Jet Trip To Paris
Updated: October 26, 2009
Pharmaceutical companies are always looking for two things – people to participate in their clinical trials and new ways to market their products, but it is important to point out that clinical trial recruitment is never associated with marketing programs.
Cephalon, an international biopharmaceutical company dedicated to the discovery, development, and commercialization of many unique products including central nervous system disorders makes a drug called Nuvigil.
As reported in the Daily News, ads started appearing with the following question: "Want to fly to France and get paid $2,500 for your trouble?"
Cephalon conducted a randomized, double-blind, placebo-controlled clinical trial of 427 patients with excessive sleepiness associated with jet lag disorder in eastbound travel. This trial was conducted by flying participants from the east coast of the U.S. to Basel, Switzerland, where they were transported directly by bus to a research sleep facility located in France. Private jets were used to provide a proper, controlled research environment. This would not have been possible using regularly scheduled commercial airline flights.
Study participants were given either study medication (armodafinil) or a sugar pill (placebo). This Phase III clinical trial was conducted following the review and approval of the protocol by an institutional review board (also known as an Ethics Committee). Institutional review boards approve, monitor, and review biomedical and behavioral research, including recruitment activities, with the aim to protect the rights and welfare of the research participants. This study was conducted under an Investigational New Drug (IND) application with the FDA because armodafinil, the study medication, is not approved for the treatment of jet lag disorder or its associated symptoms.
Information about the study may be found at the following link: http://www.cephalon.com/media/
Editors Note: This article was updated on 11-03-09 with accurate information provided by Cephalon.